Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2025-12-25 @ 7:00 PM
Study NCT ID:
NCT04689204
Status:
COMPLETED
Last Update Posted:
2025-01-24
First Post:
2020-12-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies
Sponsor:
He Huang
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-25
First Submit QC Date:
None
Study First Post Date:
2020-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-21
Last Update Post Date:
2025-01-24
Last Update Post Date Type:
ACTUAL